Stephen B Hanauer Selected Research

infliximab (Remicade)

12/2007	Immunosuppressive therapy in the formation of antibodies to infliximab in Crohn's disease.
06/2007	Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.
04/2007	The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.
01/2007	Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab.
03/2006	Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
12/2005	Infliximab for induction and maintenance therapy for ulcerative colitis.
10/2005	Infliximab or cyclosporine for severe ulcerative colitis.
07/2005	Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. A BALANCING VIEW: lifetime channeling of infliximab for crohn's disease.
07/2004	Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease.
02/2004	Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.
05/2003	Immunogenicity of infliximab in Crohn's disease.
05/2003	A lupus-like syndrome associated with infliximab therapy.
12/2002	Infliximab in the treatment of Crohn's disease: a user's guide for clinicians.
05/2002	Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

24	Crohn Disease (Crohn's Disease) 12/2007 - 05/2002
8	Ulcerative Colitis 03/2008 - 03/2003
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2007 - 12/2003
1	Pouchitis 10/2007
1	Diarrhea 05/2007
1	Thrombosis (Thrombus) 06/2005
1	Fistula 08/2003
1	Inflammation 06/2003
1	Syndrome 05/2003

14	infliximab (Remicade)FDA Link 12/2007 - 05/2002
4	Mesalamine (Mesalazine)FDA LinkGeneric 11/2005 - 05/2004
3	adalimumab (Humira)FDA Link 06/2007 - 02/2006
2	6-Mercaptopurine (Mercaptopurine)FDA LinkGeneric 02/2007 - 09/2004
2	natalizumab (Tysabri)FDA Link 01/2007 - 11/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2006 - 01/2004
2	Budesonide (Pulmicort)FDA LinkGeneric 08/2005 - 07/2002
1	rosiglitazone (Avandia)FDA Link 03/2008
1	AntibodiesIBA 12/2007
1	rifaximin (L 105)FDA Link 10/2007
1	Prednisone (Sone)FDA LinkGeneric 09/2007
1	CDP870 FDA Link 07/2007
1	Loperamide (Imodium)FDA LinkGeneric 05/2007
1	Simethicone FDA Link 05/2007
1	Azathioprine (Imuran)FDA LinkGeneric 02/2007
1	Allopurinol (Remid)FDA LinkGeneric 02/2007
1	tetomilastIBA 01/2007
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2005
1	Vitamin D FDA LinkGeneric 07/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2003
1	Tacrolimus (Prograf)FDA Link 08/2003
1	LactoferrinIBA 06/2003
1	balsalazide (Colazal)FDA LinkGeneric 03/2003
1	Sodium Glutamate (Accent)IBA 05/2002

2	Biological Therapy 12/2007 - 01/2004
1	Blood Component Removal (Apheresis) 07/2006
1	Colectomy 06/2005